International Clinical Trial: A prospective, multicenter, double-blind, randomized, placebo-controlled, cross-over design exploratory clinical trial of IIT to compare and evaluate the efficacy and safety of intramuscular injection of ketamine in improving depressive symptoms in patients with treatment-resistant major depressive disorder

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012599) titled 'A prospective, multicenter, double-blind, randomized, placebo-controlled, cross-over design exploratory clinical trial of IIT to compare and evaluate the efficacy and safety of intramuscular injection of ketamine in improving depressive symptoms in patients with treatment-resistant major depressive disorder' on Sept. 10.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Cross-over, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: Samsung Medical Center

Condition:

Mental and behavioural disorders

Intervention: Dr...